Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney disease

by Dan Wang, Zikun Zhang, Zekun Si, Yanlin Yang, Shuangshuang Li, Yaoming Xue
Published 2021-05-01